Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Neurocrine Biosciences Inc.
DescriptionSelective non-peptide corticotropin-releasing factor 1 (CRF1) receptor antagonist
Molecular Target Corticotropin-releasing factor 1 (CRF1)
Mechanism of ActionCorticotropin-releasing factor (CRF) receptor 1 antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationAdrenal insufficiency
Indication DetailsTreat congenital adrenal hyperplasia (CAH)
Regulatory Designation U.S. - Orphan Drug (Treat congenital adrenal hyperplasia (CAH))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today